New Orleans-based Oschner Children’s and the Institute for Safe Medication Practices have started a joint fellowship, aiming to train pharmacists in medication safety. The yearlong program will provide participants with hands-on experience in preventing medication errors through virtual learning with…
Pharmacy
The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies around access, financial management and workforce preparedness. These therapies, including cell and gene treatments, present certain financial and logistical hurdles that require special planning…
GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending for the first time, according to a March 25 report from Evernorth. The report is based on data collected from scientific literature,…
Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail pharmacies for a reduced cost of $499 per month. Previously this option was available only through the recently launched NovoCare Pharmacy, according…
The DEA and HHS have postponed the implementation of the final rule on telemedicine prescribing of buprenorphine to Dec. 31. The rule was initially set to take effect on Feb. 18. That date was pushed to March 21 and now…
A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly inherited Alzheimer’s disease. The study, published in The Lancet, involved 73 participants across…
Novo Nordisk and United Laboratories International’s subsidiary, United Biotechnology Co. have entered into a potentially $2 billion license agreement for UBT251, a glucagon triple-receptor agonist in early stage clinical development for obesity, Type 2 diabetes and other diseases. Novo Nordisk…
The FDA found concerns at a factory in India that makes generic drugs for U.S. patients including one drug that was manufactured at the facility and has been linked to at least eight deaths, ProPublica reported March 20. The agency…
Richmond-based Virginia Commonwealth University is launching an accelerated program during the fall that allows students to earn both a Bachelor of Science in pharmaceutical sciences and a Doctor of Pharmacy degree in seven years instead of eight. The program aims…
Effective March 20, Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics. Optum Rx said the new pharmacy payment models are in response to price increases set by brand name drug manufacturers. “With this…